<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://harvardscience.harvard.edu" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>all David M. Nathan stories</title>
 <link>http://harvardscience.harvard.edu/stories/person/20193</link>
 <description>Stories and external links referencing a person (RSS)</description>
 <language>en</language>
<item>
 <title>Initial human trial of Type 1 diabetes treatment begun</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/initial-human-trial-type-1-diabetes-treatment-begun</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Scientists at the &lt;a title=&quot;&quot; href=&quot;http://www.massgeneral.org/&quot;&gt;Massachusetts General Hospital&lt;/a&gt; (MGH) have initiated a phase 1 clinical trial to reverse &lt;a title=&quot;&quot; href=&quot;http://www.diabetes.org/type-1-diabetes.jsp&quot;&gt;type 1 diabetes&lt;/a&gt;. The trial is exploring whether the promising results from the laboratory of &lt;a title=&quot;&quot; href=&quot;http://harvardscience.harvard.edu/directory/researchers/denise-faustman-0&quot;&gt;Denise Faustman&lt;/a&gt;, Associate Professor of Medicine at &lt;a title=&quot;&quot; href=&quot;http://www.hms.harvard.edu&quot;&gt;Harvard Medical School&lt;/a&gt;, can be applied in human diabetes.&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/initial-human-trial-type-1-diabetes-treatment-begun&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Thu, 13 Mar 2008 15:11:30 -0400</pubDate>
 <dc:creator>404132862</dc:creator>
 <guid isPermaLink="false">20192 at http://harvardscience.harvard.edu</guid>
</item>
</channel>
</rss>
